4.2 Article

Gonadal mosaicism and familial adenomatous polyposis

Journal

FAMILIAL CANCER
Volume 7, Issue 2, Pages 173-177

Publisher

SPRINGER
DOI: 10.1007/s10689-007-9169-1

Keywords

familial adenomatous polyposis (FAP); gonadal mosaicism; de novo mutation; adenomatous polyposis coli (APC)

Funding

  1. NCI NIH HHS [R01-CA040641, P01-CA073992] Funding Source: Medline

Ask authors/readers for more resources

De novo mutations in the adenomatous polyposis coli (APC) gene are estimated to constitute approximately 25% of familial adenomatous polyposis (FAP) cases. A small percentage of these arise in the mosaic form, affecting only a subset of cells in the affected individual. A family is described here whereby an unaffected mother with no detectible mutation in APC, transmitted the identical APC c.4729G>T (p.Glu1577X) mutation to two children. A third child, with the same APC allelic haplotype received a normal APC allele, suggesting that the mutation originated in the gonadal tissues of the mother. These results underscore the utility of mutation-specific genetic testing for the parents and siblings of a proband of an adult-onset disease, even if the proband appears to have a de novo mutation. Parents who test negative for the mutation should be counseled about the possibility of having another affected child due to gonadal mosaicism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available